Cargando…
Cancer-selective, single agent chemoradiosensitising gold nanoparticles
Two nanometre gold nanoparticles (AuNPs), bearing sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine), were synthesised and evaluated for their in vitro toxicity and ability to radiosensitise cells with 220 kV and 6 MV X-rays, using four cell lines representing normal and cancerous ski...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507319/ https://www.ncbi.nlm.nih.gov/pubmed/28700660 http://dx.doi.org/10.1371/journal.pone.0181103 |
_version_ | 1783249717440806912 |
---|---|
author | Grellet, Sophie Tzelepi, Konstantina Roskamp, Meike Williams, Phil Sharif, Aquila Slade-Carter, Richard Goldie, Peter Whilde, Nicky Śmiałek, Małgorzata A. Mason, Nigel J. Golding, Jon P. |
author_facet | Grellet, Sophie Tzelepi, Konstantina Roskamp, Meike Williams, Phil Sharif, Aquila Slade-Carter, Richard Goldie, Peter Whilde, Nicky Śmiałek, Małgorzata A. Mason, Nigel J. Golding, Jon P. |
author_sort | Grellet, Sophie |
collection | PubMed |
description | Two nanometre gold nanoparticles (AuNPs), bearing sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine), were synthesised and evaluated for their in vitro toxicity and ability to radiosensitise cells with 220 kV and 6 MV X-rays, using four cell lines representing normal and cancerous skin and breast tissues. Acute 3 h exposure of cells to AuNPs, bearing PEG-amine only or a 50:50 ratio of alpha-galactose derivative and PEG-amine resulted in selective uptake and toxicity towards cancer cells at unprecedentedly low nanomolar concentrations. Chemotoxicity was prevented by co-administration of N-acetyl cysteine antioxidant, or partially prevented by the caspase inhibitor Z-VAD-FMK. In addition to their intrinsic cancer-selective chemotoxicity, these AuNPs acted as radiosensitisers in combination with 220 kV or 6 MV X-rays. The ability of AuNPs bearing simple ligands to act as cancer-selective chemoradiosensitisers at low concentrations is a novel discovery that holds great promise in developing low-cost cancer nanotherapeutics. |
format | Online Article Text |
id | pubmed-5507319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55073192017-07-25 Cancer-selective, single agent chemoradiosensitising gold nanoparticles Grellet, Sophie Tzelepi, Konstantina Roskamp, Meike Williams, Phil Sharif, Aquila Slade-Carter, Richard Goldie, Peter Whilde, Nicky Śmiałek, Małgorzata A. Mason, Nigel J. Golding, Jon P. PLoS One Research Article Two nanometre gold nanoparticles (AuNPs), bearing sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine), were synthesised and evaluated for their in vitro toxicity and ability to radiosensitise cells with 220 kV and 6 MV X-rays, using four cell lines representing normal and cancerous skin and breast tissues. Acute 3 h exposure of cells to AuNPs, bearing PEG-amine only or a 50:50 ratio of alpha-galactose derivative and PEG-amine resulted in selective uptake and toxicity towards cancer cells at unprecedentedly low nanomolar concentrations. Chemotoxicity was prevented by co-administration of N-acetyl cysteine antioxidant, or partially prevented by the caspase inhibitor Z-VAD-FMK. In addition to their intrinsic cancer-selective chemotoxicity, these AuNPs acted as radiosensitisers in combination with 220 kV or 6 MV X-rays. The ability of AuNPs bearing simple ligands to act as cancer-selective chemoradiosensitisers at low concentrations is a novel discovery that holds great promise in developing low-cost cancer nanotherapeutics. Public Library of Science 2017-07-10 /pmc/articles/PMC5507319/ /pubmed/28700660 http://dx.doi.org/10.1371/journal.pone.0181103 Text en © 2017 Grellet et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Grellet, Sophie Tzelepi, Konstantina Roskamp, Meike Williams, Phil Sharif, Aquila Slade-Carter, Richard Goldie, Peter Whilde, Nicky Śmiałek, Małgorzata A. Mason, Nigel J. Golding, Jon P. Cancer-selective, single agent chemoradiosensitising gold nanoparticles |
title | Cancer-selective, single agent chemoradiosensitising gold nanoparticles |
title_full | Cancer-selective, single agent chemoradiosensitising gold nanoparticles |
title_fullStr | Cancer-selective, single agent chemoradiosensitising gold nanoparticles |
title_full_unstemmed | Cancer-selective, single agent chemoradiosensitising gold nanoparticles |
title_short | Cancer-selective, single agent chemoradiosensitising gold nanoparticles |
title_sort | cancer-selective, single agent chemoradiosensitising gold nanoparticles |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507319/ https://www.ncbi.nlm.nih.gov/pubmed/28700660 http://dx.doi.org/10.1371/journal.pone.0181103 |
work_keys_str_mv | AT grelletsophie cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT tzelepikonstantina cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT roskampmeike cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT williamsphil cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT sharifaquila cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT sladecarterrichard cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT goldiepeter cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT whildenicky cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT smiałekmałgorzataa cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT masonnigelj cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles AT goldingjonp cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles |